PS101-mediated adoptive cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PS101-mediated adoptive cell therapy, covering 2024-10-10 to 2024-10-10. Get the full timeline:
Most recent: Clinical Trial Update: PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin [Phase 1]